These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33386794)

  • 1. LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1.
    Zheng H; Zhang M; Ke X; Deng X; Li D; Wang Q; Yan S; Xue Y; Wang Q
    Cancer Biomark; 2021; 30(4):395-406. PubMed ID: 33386794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
    Liu A; Liu L; Lu H
    J Cell Physiol; 2019 Aug; 234(8):13747-13761. PubMed ID: 30656681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
    Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
    Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer.
    Liu X; Cui L; Hua D
    Oncol Res; 2018 Dec; 27(1):99-106. PubMed ID: 29495975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells.
    Zhang R; Wang Z; Yu Q; Shen J; He W; Zhou D; Yu Q; Fan J; Gao S; Duan L
    J Cell Mol Med; 2019 May; 23(5):3151-3165. PubMed ID: 30907503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
    Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
    Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells.
    Gao Z; Zhou H; Wang Y; Chen J; Ou Y
    J Cell Biochem; 2020 Jan; 121(1):332-343. PubMed ID: 31222825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
    Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3.
    Deng X; Li D; Ke X; Wang Q; Yan S; Xue Y; Wang Q; Zheng H
    J Clin Lab Anal; 2021 Jan; 35(1):e23578. PubMed ID: 32990355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
    Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
    Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
    Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer.
    Chen DL; Chen LZ; Lu YX; Zhang DS; Zeng ZL; Pan ZZ; Huang P; Wang FH; Li YH; Ju HQ; Xu RH
    Cell Death Dis; 2017 Aug; 8(8):e3011. PubMed ID: 28837144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial-mesenchymal transition underlying colorectal cancer exacerbation.
    Bai J; Xu J; Zhao J; Zhang R
    J Cell Physiol; 2020 Feb; 235(2):1453-1468. PubMed ID: 31276207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect.
    Sun Y; Zhao X; Zhou Y; Hu Y
    Oncol Rep; 2012 Oct; 28(4):1346-52. PubMed ID: 22895557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis.
    Chen GQ; Liao ZM; Liu J; Li F; Huang D; Zhou YD
    Biochem Genet; 2021 Apr; 59(2):560-573. PubMed ID: 33389283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer.
    Xing Y; Lin B; Liu B; Shao J; Jin Z
    Curr Cancer Drug Targets; 2024; 24(10):1071-1079. PubMed ID: 38243936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.